Table 4.
Clinical features of imported microscopic malaria and SMM
|
Clinical features by group |
|||
|---|---|---|---|
| Microscopic malaria | Submicroscopic malaria | p value | |
|
Time to diagnosis (days) |
11 (0-730) |
12 (0-1544) |
0.276 (M) |
|
Symptomatic |
168 (88.9%) |
30 (28.8%) |
< 0.001 |
|
Liver enlargement |
17 (9%) |
11 (10.6%) |
0.0659 |
|
Spleen enlargement |
29 (15.3%) |
14 (13.5%) |
0.663 |
|
Asthenia |
153 (91.1%) |
22 (73.3%) |
0.011 (F) |
|
Headache |
119 (70.8%) |
12 (40%) |
0.001 |
|
Ocular pain |
39 (23.2%) |
3 (10%) |
0.103 |
|
Arthromyalgia |
116 (69%) |
16 (53.3%) |
0.093 |
|
Vomiting |
36 (21.4%) |
2 (6.7%) |
0.059 |
|
Diarrhoea |
37 (22%) |
2 (6.7%) |
0.051 |
|
Rash |
1 (0.6%) |
1 (3.3%) |
0.281 (F) |
|
Cough |
4 (2.4%) |
2 (6.7%) |
0.226 (F) |
|
Abdominal pain |
5 (3%) |
2 (6.7%) |
0.287 |
|
Fever |
160 (95.2%) |
18 (60%) |
< 0.001 (F) |
|
Tropical splenomegaly |
3 (1.8%) |
4 (13.3%) |
0.011 (F) |
| Severe malaria | 13 (6.9%) | 0 (0%) | 0.005 (F) |
Abbreviations (in alphabetical order). F: Test de Fisher. M: Test de Mann–Whitney.